Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Compounds for reactivation of acetylcholinesterase and related compositions methods and systems

Patent ·
OSTI ID:1637828

Described herein are oxime compounds capable of inactivating a nerve agent, blood brain barrier (BBB)-penetration, and/or reactivation of nerve agent-inhibited acetylcholinesterase (AChE) and related methods, systems and compositions for inactivation of one or more nerve agents, therapeutic and/or prophylactic treatment of an individual, and/or decomposition of nerve agent for decontamination.

Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-07NA27344
Assignee:
Lawrence Livermore National Security, LLC (Livermore, CA)
Patent Number(s):
10,590,498
Application Number:
15/595,400
OSTI ID:
1637828
Country of Publication:
United States
Language:
English

References (20)

Molecular Dynamics Simulations of Ligand Recognition upon Binding Antithrombin: A MM/GBSA Approach book January 2015
A Novel Design of Artificial Membrane for Improving the PAMPA Model journal January 2008
A new and rapid colorimetric determination of acetylcholinesterase activity journal July 1961
Report on 640 Victims of the Tokyo Subway Sarin Attack journal August 1996
Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase journal April 2014
A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations journal August 2014
The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs journal November 2017
The Tokyo subway sarin attack—lessons learned journal September 2005
Predicting a Drug’s Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data journal May 2017
Decontamination of chemical warfare agents journal December 1992
Nonquaternary Reactivators for Organophosphate-Inhibited Cholinesterases journal December 2011
Syrian gas attack reinforces need for better anti-sarin drugs journal October 2013
Chemical approaches for detection and destruction of nerve agents journal January 2013
Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases journal February 2012
In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System journal October 2007
A Novel Method for the Preparation of Optically Active Dipeptide. Chemo- and Stereoselective Reduction of 2-Hydroxyimino Amides with Samarium Diiodide. journal January 1992
Structure of HI-6•Sarin-Acetylcholinesterase Determined by X-Ray Crystallography and Molecular Dynamics Simulation: Reactivator Mechanism and Design journal June 2009
Decontamination of Chemical Warfare Agents [English] journal May 2010
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family journal January 2005
Development and Structural Modifications of Cholinesterase Reactivators against Chemical Warfare Agents in Last Decade: A Review journal February 2015